0.5 ML Hepatitis-B Vaccine IP

Get a Price/Quote

MOQ : 50 Packs

0.5 ML Hepatitis-B Vaccine IP Specification

Salt Composition
Hepatitis B surface antigen (rDNA)

Indication
Prevention of Hepatitis B virus infection

Dosage Form
Injection

Life Span
36 months from date of manufacture

Origin of Medicine
India

Packaging Type
Glass vial with rubber stopper

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Allopathic

Ingredients
Recombinant Hepatitis B Surface Antigen (rDNA)

Physical Form
Liquid solution

Function
Prevention of Hepatitis B infection

Recommended For
Active immunization against Hepatitis B in infants, children, adolescents, and adults

Dosage
0.5 ml per dose

Dosage Guidelines
As directed by physician or as per immunization schedule

Suitable For
Adults, Children, Infants

Quantity
Single dose vial

Storage Instructions
Store between 2C to 8C. Do not freeze.

pH Range
6.0 - 7.4

Colour
Colourless to slightly opalescent

Volume Per Dose
0.5 ml

Side Effects
Mild fever, pain or redness at injection site, rarely allergic reactions

Contraindications
Known hypersensitivity to any component of the vaccine or previous dose

Preservatives
Thiomersal (as permitted)

Route of Administration
Intramuscular injection

Use
For intramuscular administration only

Schedule
For infants: 0, 1, and 6 months as per immunization schedule

0.5 ML Hepatitis-B Vaccine IP Trade Information

Minimum Order Quantity
50 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 0.5 ML Hepatitis-B Vaccine IP

Hepatitis-B Vaccine IP 0.5 ML is highly recommended for active immunization against Hepatitis B in all age groups. This champion product comes as a single dose in a glass vial with a secure rubber stopper and is suitable for infants, children, adolescents, and adults. The superior, colourless to slightly opalescent liquid is administered intramuscularly and incorporates the trusted virtuoso ingredient: Recombinant Hepatitis B Surface Antigen (rDNA). Jump on our current promotion for this essential vaccine-crafted in India and preserved with safety in mind-for unmatched disease prevention.

Superior Protection with Hepatitis-B Vaccine IP

The 0.5 ML Hepatitis-B Vaccine IP is specially used for active prevention of Hepatitis B infection in adults, children, and infants. Designed as an intramuscular injection, this allopathic vaccine offers robust immunity and follows an easy-to-schedule administration. Key features include its colourless liquid form, well-regulated pH, long shelf life, and compliance with safety standards, making it highly effective for routine immunization across all ages.

Reliable Supply & Export Facilities for Hepatitis-B Vaccine IP

We offer dependable supply abilities and swift order completion for the 0.5 ML Hepatitis-B Vaccine IP. With express shipping options available, deliveries can be organized through major Indian FOB ports. Our main export markets include Asia, Africa, and the Middle East. Jump on our offer today to ensure protection and health for your region with timely and secure vaccine supplies.

FAQ's of 0.5 ML Hepatitis-B Vaccine IP:

Q: How should the 0.5 ML Hepatitis-B Vaccine IP be administered?

A: The vaccine is administered as an intramuscular injection, typically in the deltoid region for adults and children, and the anterolateral thigh for infants, as per physician directions.

Q: What is the usage schedule for infants with Hepatitis-B Vaccine IP?

A: Infants should receive the vaccine at 0, 1, and 6 months according to the recommended immunization schedule, or as guided by their healthcare provider.

Q: What are the benefits of using Hepatitis-B Vaccine IP?

A: This vaccine offers superior protection against Hepatitis B infection, helping prevent serious liver disease by building immunity in individuals of all ages.

Q: When should this vaccine not be given?

A: The vaccine is contraindicated in individuals with known hypersensitivity to any component of the vaccine or after a previous dose that resulted in allergic reactions.